BridgeBio Pharma Inc. (BBIO)

AI Score

Unlock

33.87

0.02 (0.06%)

At close: Apr 17, 2025, 3:59 PM

33.20

-1.98%

After-hours: Apr 17, 2025, 07:06 PM EDT

BridgeBio Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q1 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Mar 31, 2018
Cash & Equivalents	681.1M	266.32M	407.96M	475.35M	375.94M	505.21M	302.44M	407.37M	376.69M	483.24M	470.1M	371.55M	393.77M	180.35M	378.42M	471.18M	356.08M	366.97M	540.92M	757.05M	363.77M	413.97M	293.8M	373.03M	436.09M	-92M
Short-Term Investments	n/a	n/a	39.81M	44.47M	58.95M	38.05M	333.31M	34.12M	95.23M	108.74M	245.61M	299.68M	442.89M	419.26M	459.24M	447.94M	251.01M	343.71M	300.02M	148.13M	182.22M	122.08M	n/a	n/a	n/a	183.99M
Long-Term Investments	143.75M	160.44M	119.15M	3.94M	3.74M	38.05M	50.49M	49.8M	43.65M	11.61M	2.41M	2.47M	49.15M	17.71M	18.89M	82.2M	n/a	n/a	n/a	23.21M	31.14M	76.79M	7.5M	12.45M	17.05M	n/a
Other Long-Term Assets	18.2M	20.29M	16.76M	16.78M	22.63M	18.68M	20.4M	20.77M	20.22M	29.87M	31.32M	32.86M	33.03M	33.05M	49.8M	30.18M	23.93M	16.48M	17.25M	-6.19M	-4.86M	2.6M	9.47M	4.57M	1.09M	-92M
Receivables	4.72M	478K	660K	235.49M	1.75M	5.17M	8.61M	10.76M	17.08M	24.58M	22.82M	10.98M	19.75M	8.17M	1.21M	462K	n/a	8M	n/a	n/a	2.85M	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	16.65M	16.65M	19.93M	25.5M	37.93M	n/a	1.00	n/a	1.00	n/a	1.21M	n/a	n/a	n/a	n/a	n/a	-2.85M	n/a	n/a	n/a	n/a	n/a
Other Current Assets	34.87M	177.78M	139.41M	131K	27.65M	16.65M	19.93M	25.5M	37.93M	n/a	n/a	n/a	177K	n/a	44.5M	n/a	35.73M	n/a	21M	19.78M	22.63M	13.35M	5.37M	2.28M	n/a	n/a
Total Current Assets	720.69M	444.58M	616.24M	783.42M	477.59M	549.62M	382.4M	502.9M	505.2M	642.22M	771.28M	716.23M	839.71M	639.71M	970.56M	945.11M	642.82M	745.38M	861.93M	948.17M	599.77M	558.15M	306.71M	382.47M	445.22M	92M
Property-Plant & Equipment	12.78M	15.14M	17.11M	19.47M	19.84M	21.75M	22.86M	24.1M	25.25M	27.34M	29.72M	31.12M	45.97M	44.85M	42.24M	35.81M	36.83M	25.83M	26.04M	24.61M	5.63M	2.98M	1.86M	1.88M	1.57M	n/a
Goodwill & Intangibles	23.93M	24.52M	25.12M	25.72M	26.32M	26.92M	27.52M	28.11M	28.71M	29.31M	29.91M	30.48M	44.93M	46.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	198.65M	220.4M	178.14M	65.91M	68.79M	105.39M	121.26M	122.78M	117.84M	86.52M	90.95M	96.92M	173.08M	141.81M	110.93M	148.19M	60.76M	42.31M	43.29M	41.63M	31.91M	82.38M	18.83M	18.9M	19.72M	-92M
Total Assets	919.34M	664.98M	794.38M	849.33M	546.38M	655.01M	503.66M	625.68M	623.04M	728.74M	862.23M	813.15M	1.01B	781.52M	1.08B	1.09B	703.59M	787.69M	905.23M	989.8M	631.68M	640.53M	325.54M	401.37M	464.94M	n/a
Account Payables	9.62M	13.36M	18.13M	4.73M	10.65M	4.47M	3.87M	4.08M	11.56M	10.16M	8.79M	10.11M	11.88M	12.04M	22.33M	10.34M	8.95M	9.84M	12.84M	13.09M	8.85M	10.27M	16.07M	12.34M	13.51M	n/a
Deferred Revenue	31.7M	11.77M	15.1M	13.96M	6.1M	6.59M	6.21M	6.67M	8.16M	7.52M	7.19M	n/a	n/a	n/a	-4.54M	n/a	75.9M	57.05M	70.9M	43.27M	31.45M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	4.62M	4.54M	4.13M	n/a	3.78M	3.67M	n/a	n/a	4.31M	4.36M	n/a	n/a	n/a	7.45M	1.46M	3.62M	3.63M	2.51M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	43.54M	62.84M	81.31M	61.47M	57.13M	63.79M	59.63M	66.78M	72.63M	83.95M	69.17M	1.5M	3.5M	21.86M	52.39M	9.55M	20.34M	15.24M	6.68M	4.08M	4.02M	4.3M	4.52M	4.01M	n/a
Total Current Liabilities	41.32M	139.22M	134.36M	141.48M	143.84M	101.93M	106.34M	92.92M	117.75M	119.19M	141.16M	103.46M	130.13M	95.82M	127.37M	94.73M	91.85M	75.71M	92.64M	62.4M	52.38M	39.86M	38.7M	35.47M	32.58M	n/a
Long-Term Debt	1.72B	1.72B	1.72B	1.72B	1.73B	1.72B	1.72B	1.71B	1.71B	1.7B	1.69B	1.71B	1.7B	1.38B	1.37B	1.36B	475.86M	471.89M	466.56M	461.34M	91.79M	75.02M	75M	54.86M	54.51M	n/a
Other Long-Term Liabilities	479.38M	377K	485K	595K	9.36M	11.79M	13.33M	17.5M	26.64M	28.23M	28.63M	26.83M	22.07M	26.25M	11.85M	11.61M	9.52M	13.47M	9.4M	2.8M	3.53M	1.39M	479.39M	380K	479.36M	n/a
Total Long-Term Liabilities	2.22B	1.74B	1.74B	1.74B	1.75B	1.75B	1.75B	1.75B	1.75B	1.74B	1.74B	1.75B	1.75B	1.42B	1.41B	1.39B	503.85M	493.6M	485.07M	475.32M	103.32M	76.41M	554.39M	55.24M	533.87M	n/a
Total Liabilities	2.38B	1.88B	1.88B	1.89B	1.89B	1.85B	1.85B	1.84B	1.87B	1.86B	1.88B	1.85B	1.88B	1.52B	1.54B	1.48B	595.7M	569.31M	577.72M	537.73M	155.7M	116.26M	593.09M	90.71M	566.44M	n/a
Total Debt	1.73B	1.73B	1.73B	1.73B	1.74B	1.74B	1.73B	1.73B	1.72B	1.72B	1.71B	1.73B	1.73B	1.4B	1.4B	1.38B	495.79M	483.75M	479.3M	472.53M	99.79M	75.02M	75M	54.86M	54.51M	n/a
Common Stock	n/a	195K	194K	193K	181K	180K	168K	167K	157K	156K	154K	154K	154K	153K	153K	152K	125K	125K	125K	124K	124K	117K	9.95M	100K	6.59M	n/a
Retained Earnings	-3.1B	-2.83B	-2.67B	-2.6B	-2.56B	-2.39B	-2.22B	-2.06B	-1.92B	-1.78B	-1.64B	-1.63B	-1.44B	-1.29B	-1.13B	-1.04B	-888.75M	-768.77M	-652.91M	-531.88M	-440.03M	-366.57M	-326.07M	-234.73M	-170.58M	n/a
Comprehensive Income	n/a	5K	-4K	2K	31K	34K	63K	-12K	-328K	-348K	-427K	-383K	-132K	19K	36K	-57K	192K	461K	858K	726K	254K	152K	n/a	-479.04M	-231K	-61.43M
Shareholders Equity	-1.47B	-1.23B	-1.09B	-1.05B	-1.35B	-1.21B	-1.36B	-1.23B	-1.25B	-1.14B	-1.03B	-1.04B	-870.41M	-743.4M	-464.29M	-395.29M	57.91M	163.76M	265.76M	380.71M	408.45M	459.76M	-316.12M	252.14M	-163.99M	85.77M
Total Investments	143.75M	160.44M	158.96M	48.41M	58.95M	38.05M	333.31M	34.12M	138.89M	108.74M	245.61M	299.68M	442.89M	436.97M	538.83M	530.14M	251.01M	343.71M	300.02M	171.34M	213.36M	198.87M	7.5M	12.45M	17.05M	183.99M